Literature DB >> 14986048

Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.

Masami Iizuka-Mikami1, Kiyohisa Nagai, Koji Yoshida, Takashi Sugihara, Yoshimasa Suetsugu, Makoto Mikami, Tsutomu Tamada, Shigeki Imai, Yasumasa Kajihara, Masao Fukunaga.   

Abstract

The aim of this study was to evaluate the diagnostic potential of whole-body MRI (WB-MRI) for the detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma. WB-MRI, which was performed on 34 patients, consisted of the recording of T1-weighted spin-echo images and a fast STIR sequence covering the entire skeleton. The WB-MRI findings for bone marrow and extramedullary involvement were compared with those from (67)Ga and bone scintigraphies and bone marrow biopsy results. Two MRI specialists reviewed the WB-MRI results and two expert radiologists in the field of nuclear medicine reviewed the bone and (67)Ga scintigraphy findings. Bone marrow and extramedullary involvement of non-Hodgkin's lymphoma were confirmed by follow-up radiographs and CT and/or a histological biopsy. The detection rate of WB-MRI was high. More bone marrow involvement was detected by biopsy, and more lesions were detected by scintigraphies. In total, 89 lesions were detected by WB-MRI, whereas 15 were found by biopsy, 5 by (67)Ga scintigraphy, and 14 by bone scintigraphy. WB-MRI could also detect more extramedullary lesions than (67)Ga scintigraphy; i.e., 72 lesions were detected by WB-MRI, whereas 54 were discovered by (67)Ga scintigraphy. WB-MRI is useful for evaluating the involvement of bone marrow and extramedullary lesions throughout the skeleton in patients with non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986048     DOI: 10.1007/s00330-003-2209-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases.

Authors:  R D Brunning; C D Bloomfield; R W McKenna; L A Peterson
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

2.  Whole body turbo STIR MRI in unknown primary tumor detection.

Authors:  S Eustace; R Tello; V DeCarvalho; J Carey; E Melhem; E K Yucel
Journal:  J Magn Reson Imaging       Date:  1998 May-Jun       Impact factor: 4.813

Review 3.  Magnetic resonance imaging of the bone marrow in hematologic malignancies.

Authors:  L A Moulopoulos; M A Dimopoulos
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

4.  Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.

Authors:  A Y Lee; J M Connors; P Klimo; S E O'Reilly; R D Gascoyne
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

5.  Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.

Authors:  H Schöder; J Meta; C Yap; M Ariannejad; J Rao; M E Phelps; P E Valk; J Sayre; J Czernin
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

6.  Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma.

Authors:  S Tsunoda; S Takagi; O Tanaka; Y Miura
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

7.  Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin-echo, chemical-shift, and STIR MR imaging.

Authors:  L L Baker; S B Goodman; I Perkash; B Lane; D R Enzmann
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

Review 8.  Magnetic resonance imaging in patients with bone marrow disorders.

Authors:  W Negendank; R L Soulen
Journal:  Leuk Lymphoma       Date:  1993-07

9.  Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.

Authors:  B R Hoane; A F Shields; B A Porter; H M Shulman
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

10.  Lymphoma of the skeleton: scintigraphic evaluation.

Authors:  J A Orzel; N W Sawaf; M L Richardson
Journal:  AJR Am J Roentgenol       Date:  1988-05       Impact factor: 3.959

View more
  14 in total

1.  [Possibilities of whole-body MRI for investigating musculoskeletal diseases].

Authors:  S Lenk; S Fischer; I Kötter; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

Review 2.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

3.  Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.

Authors:  Nadir Ghanem; Christian Lohrmann; Monika Engelhardt; Gregor Pache; Markus Uhl; Ulrich Saueressig; Elmar Kotter; Mathias Langer
Journal:  Eur Radiol       Date:  2006-02-04       Impact factor: 5.315

Review 4.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

5.  Image quality improvement of composed whole-spine MR images by applying a modified homomorphic filter--first results in cases of multiple myeloma.

Authors:  M P Lichy; C Mueller-Horvat; V Jellus; W Horger; M Horger; C Pfannenberg; B Kiefer; C D Claussen; H P Schlemmer
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

6.  Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy.

Authors:  Hyun Woo Goo; Dong Hyun Yang; Young Shin Ra; Joon Sup Song; Ho Joon Im; Jong Jin Seo; Thad Ghim; Hyung Nam Moon
Journal:  Pediatr Radiol       Date:  2006-07-29

7.  Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.

Authors:  Hyun Woo Goo; Seong Hoon Choi; Thad Ghim; Hyung Nam Moon; Jong Jin Seo
Journal:  Pediatr Radiol       Date:  2005-04-28

8.  Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas.

Authors:  Stephan Metz; Stefanie Lohr; Marcus Settles; Ambros Beer; Klaus Woertler; Ernst J Rummeny; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2005-11-12       Impact factor: 5.315

9.  Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions.

Authors:  Hans-J Mentzel; K Kentouche; D Sauner; C Fleischmann; S Vogt; D Gottschild; F Zintl; W A Kaiser
Journal:  Eur Radiol       Date:  2004-07-09       Impact factor: 5.315

10.  [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors].

Authors:  N Ghanem; T Kelly; C Altehoefer; J Winterer; O Schäfer; T A Bley; E Moser; M Langer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.